Skip to main content

Table 5 Contingency table for test performance for ovarian cancer

From: Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours

Type of tumour(n) Sensitivity(%) Specificity (%)
(95%CI(%)) (95%CI(%))
Endometrial cancer (41) 87.8 (73.8-95.9) 75.9 (62.8-86.1)
 Low grade(14) 85.7 (57.2-98.2) -
 High Grade(27) 88.9 (70.8-97.7) -
 Stage I (29) 86.2 (68.3-96.1) -
 Stage II and above(12) 91.7 (61.5-99.8) -
Ovarian cancer(26) 61.5 (40.6-79.8) 75.9 (62.8-86.1)
 Low Grade(7) 71.4 (29.0-96.3) -
 High Grade(19) 57.9 (33.5-79.8) -
 Stage I(8) 75.0 (34.9-96.8) -
 Stage II and above(15) 53.3 (26.6-78.7) -